GBIO Generation Bio Co
Price (delayed)
$0.3921
Market cap
$26.27M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.98
Enterprise value
$41.38M
Generation Bio is an innovative genetic medicines company focused on creating a new class of non-viral gene therapy to provide durable, redosable treatments for people living with rare and prevalent
Highlights
Generation Bio's EPS has increased by 10% from the previous quarter
GBIO's revenue is up by 7% since the previous quarter
The net income has grown by 9% from the previous quarter but it has contracted by 4% YoY
The equity has shrunk by 58% YoY and by 17% QoQ
The quick ratio has contracted by 22% YoY and by 14% from the previous quarter
Key stats
What are the main financial stats of GBIO
Market
Valuations
Earnings
Shares outstanding
67.01M
Market cap
$26.27M
Enterprise value
$41.38M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.3
Price to sales (P/S)
1.31
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.08
Revenue
$19.89M
Gross profit
$19.89M
Operating income
-$142.39M
Net income
-$131.67M
EBIT
-$131.67M
EBITDA
-$126.74M
Free cash flow
-$90.77M
Per share
Balance sheet
Liquidity
EPS
-$1.98
EPS diluted
-$1.98
Free cash flow per share
-$1.36
Book value per share
$1.29
Revenue per share
$0.3
TBVPS
$3.47
Total assets
$231.2M
Total liabilities
$144.99M
Debt
$93.56M
Equity
$86.2M
Working capital
$157.85M
Debt to equity
1.09
Current ratio
5.5
Quick ratio
5.38
Net debt/EBITDA
-0.12
Margins
Efficiency
Dividend
EBITDA margin
-637.1%
Gross margin
100%
Net margin
-661.9%
Operating margin
-715.8%
Return on assets
-51.1%
Return on equity
-120.2%
Return on invested capital
-47.3%
Return on capital employed
-67.1%
Return on sales
-661.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
GBIO stock price
How has the Generation Bio stock price performed over time
Intraday
13.03%
1 week
12.35%
1 month
-26.02%
1 year
-86.84%
YTD
-63.01%
QTD
-3.19%
Financial performance
How have Generation Bio's revenue and profit performed over time
Revenue
$19.89M
Gross profit
$19.89M
Operating income
-$142.39M
Net income
-$131.67M
Gross margin
100%
Net margin
-661.9%
GBIO's operating margin has surged by 70% year-on-year and by 15% since the previous quarter
Generation Bio's net margin has soared by 69% YoY and by 15% from the previous quarter
The net income has grown by 9% from the previous quarter but it has contracted by 4% YoY
Generation Bio's operating income has increased by 9% QoQ but it has decreased by 2.8% YoY
Growth
What is Generation Bio's growth rate over time
Valuation
What is Generation Bio stock price valuation
P/E
N/A
P/B
0.3
P/S
1.31
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.08
Generation Bio's EPS has increased by 10% from the previous quarter
The P/B is 87% below the 5-year quarterly average of 2.0 and 82% below the last 4 quarters average of 1.5
The equity has shrunk by 58% YoY and by 17% QoQ
GBIO's price to sales (P/S) is 91% lower than its last 4 quarters average of 13.5
GBIO's revenue is up by 7% since the previous quarter
Efficiency
How efficient is Generation Bio business performance
Generation Bio's ROE has plunged by 130% YoY and by 15% from the previous quarter
Generation Bio's ROS has soared by 69% YoY and by 15% from the previous quarter
The ROA has plunged by 61% YoY and by 3.2% from the previous quarter
Generation Bio's ROIC has decreased by 30% YoY and by 2.6% from the previous quarter
Dividends
What is GBIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for GBIO.
Financial health
How did Generation Bio financials performed over time
Generation Bio's total assets is 59% higher than its total liabilities
Generation Bio's total assets has decreased by 38% YoY and by 7% QoQ
The quick ratio has contracted by 22% YoY and by 14% from the previous quarter
Generation Bio's debt is 9% more than its equity
Generation Bio's debt to equity has surged by 127% YoY and by 21% QoQ
The equity has shrunk by 58% YoY and by 17% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.